comparemela.com

Johnathon Gorman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DOACs Comparable to Warfarin in CVT

DOACs were just as effective as warfarin in preventing future thrombotic events in patients with cerebral venous thrombosis stroke, with less major bleeding, in the retrospective ACTION-CVT study.

United statesNew yorkCherry hillNew jerseyNew zealandUnited kingdomBritish columbiaColumbia universityMitchell elkindEkaterina bakradzeTudor jovinJohnathon gormanThalia fieldVancouver stroke programUniversity of alabama at birminghamInternational stroke conference

DOACs Working Out for CVT Strokes So Far

Findings of ACTION-CVT provide some reassurance

United statesNew zealandUnited kingdomBritish columbiaNicole louEkaterina bakradzeJohnathon gormanThalia fieldAmerican stroke association international conferenceVancouver stroke programUniversity of british columbiaUniversity of alabama at birminghamAmerican stroke associationInternational strokeMedpage today

ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis

The results provide reassurance that using DOACs for patients with CVT “is not an unreasonable approach,” one expert says.

United statesNew zealandUnited kingdomBritish columbiaTudor jovinJohnathon gormanBayer janssenThalia fieldShadi yaghiInternational stroke conferenceUniversity of british columbiaMd brown universityMd cooper university health careMd vancouver stroke programBrown universityVancouver stroke program

vimarsana © 2020. All Rights Reserved.